InChI=1S/C20H23BCl2N2O9/c1- 10(2) 5- 14(21- 33- 19(32) 20(34- 21,7- 16(27) 28) 8- 17(29) 30) 25- 15(26) 9- 24- 18(31) 12- 6- 11(22) 3- 4- 13(12) 23/h3- 4,6,10,14H,5,7- 9H2,1- 2H3,(H,24,31) (H,25,26) (H,27,28) (H,29,30) /t14- /m0/s1 |
MBOMYENWWXQSNW-AWEZNQCLSA-N |
C(NCC(N[C@@H](CC(C)C)B1OC(C(O1)(CC(=O)O)CC(=O)O)=O)=O)(C2=CC(=CC=C2Cl)Cl)=O |
|
Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
|
|
apoptosis inducer
Any substance that induces the process of apoptosis (programmed cell death) in multi-celled organisms.
|
|
prodrug
A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug.
proteasome inhibitor
A drug that blocks the action of proteasomes, cellular complexes that break down proteins.
orphan drug
Any drug that has been developed specifically for treatment of a rare medical condition, the condition itself being known as an orphan disease.
antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
|
|
View more via ChEBI Ontology
2,2'- {2- [(1R)- 1- {[N- (2,5- dichlorobenzoyl)glycyl]amino}- 3- methylbutyl]- 5- oxo- 1,3,2- dioxaborolane- 4,4- diyl}diacetic acid
|
MLN 9708
|
ChemIDplus
|
MLN9708
|
ChemIDplus
|
1239908-20-3
|
CAS Registry Number
|
KEGG DRUG
|
1239908-20-3
|
CAS Registry Number
|
ChemIDplus
|
27723083
|
Reaxys Registry Number
|
Reaxys
|
|